Products

EFAI ChestSuite XR Pneumothorax Assessment System
Ever Fortune AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pneumothorax Assessment System is an FDA-cleared AI-powered radiological computer-assisted triage and notification software. It uses deep learning to analyze adult PA chest X-rays for suspected pneumothorax, sending notifications to PACS/workstations to aid in worklist prioritization and clinical assessment.

See all 1 product →

About Ever Fortune AI

Ever Fortune.AI is a healthcare AI company based in Taichung, Taiwan, specializing in AI-driven diagnostic solutions for hospitals and healthcare providers. The company focuses on enhancing medical workflows and improving patient outcomes across various specialties, including oncology, neurology, and cardiovascular diseases. They offer AI-assisted diagnostics and cloud biomedical platforms designed to optimize disease monitoring and precision medicine. Their product catalog includes AI-enabled medical software for image viewing and analysis, workflow management, remote access, reporting, and clinical notification workflows. [1, 2, 3, 6]

For physicians, Ever Fortune.AI’s offerings aim to streamline diagnostic processes and provide decision support. Their systems include tools for chest X-ray interpretation, acute aortic syndrome detection, radiotherapy organ segmentation, bone scintigraphy computer-assisted detection, intracerebral hemorrhage detection, myocardial perfusion reporting, bone age assessment, STEMI detection, ECG analysis, and PACS/image management. [6] For example, their acute aortic syndrome product analyzes thoracic CT angiography to identify suspected aortic dissection and intramural hematoma, prioritizing high-risk cases. [6] The company has received regulatory clearances from both Taiwan’s TFDA and the US FDA for several of its medical software products, such as the EFAI ERSUITE CT Appendicitis Assessment System (APPEN-CT-100) for radiological computer-assisted triage and notification. [6, 9]

Focus Areas

AI-driven diagnostic solutions cloud biomedical platforms medical big data radiology cardiology oncology neurology ECG analysis PACS/image management precision medicine disease monitoring

Business Intelligence

TechnologyAI-enabled medical software, deep learning algorithms, natural language processing (NLP), convolutional neural network (CNN), recurrent neural network (RNN), cloud-native, DICOM integration

What Physicians Need to Know

AI-driven Diagnostic Solutions
Ever Fortune AI specializes in AI-powered software for medical image analysis across various disciplines. Their solutions include detecting acute intracranial hemorrhage, acute aortic syndrome, pleural effusion, appendicitis, and assessing bone age. These tools are designed to assist radiologists and emergency physicians by prioritizing urgent cases and improving diagnostic efficiency.
Cloud Biomedical Platforms & Medical Big Data
The company develops cloud biomedical platforms and leverages medical big data to create AI applications for clinical workflows. They focus on continuous innovation in big data and AI for intelligent medicine and precision medicine.
Precision Medicine
Ever Fortune AI applies AI technology driven by medical big data to precision medicine, aiming to personalize care and treatment strategies.
Medical Image Analysis
A core specialization is AI-enabled medical software for image viewing and analysis. Their products cover chest X-ray interpretation, CT angiography analysis, and radiotherapy organ segmentation.
Oncology
In oncology, Ever Fortune AI offers AI-assisted solutions for cancer radiotherapy, including automatic contouring of organs at risk in head and neck CT images to streamline treatment planning.
Neurology
Their neurology solutions include AI-based software for analyzing adult non-contrast head CT scans to detect signs of acute intracranial hemorrhage and quantify midline shift, aiding in rapid triage and surgical planning.
Cardiology
For cardiology, they have AI-powered software that analyzes CT angiography scans to detect signs of acute aortic syndrome, helping to prioritize and triage cases.
Pediatrics
In pediatrics, Ever Fortune AI provides a bone age assessment system that uses deep learning to analyze left-hand X-ray images in children aged 2 to 16 years, assisting pediatric radiologists in clinical decision-making.
Digital Medicine & Workflow Optimization
The company is committed to digital healthcare services and developing groundbreaking technology to enhance medical workflow and boost patient outcomes. Their AI tools are designed to improve efficiency in emergency departments and radiotherapy planning.
Physician Tip

Ever Fortune AI's solutions are designed as digital assistants to augment clinical decision-making, not replace it. Physicians can expect faster triage and prioritization of critical cases, reduced interpretation times for imaging studies, and improved workflow efficiency, particularly in high-pressure environments like emergency departments and radiation oncology. The systems integrate with existing PACS and Treatment Planning Systems (TPS) to minimize disruption. Always remember that these AI tools provide support and notifications, and the final clinical assessment and decision-making remain with the physician.

Ever Fortune AI's systems are designed for seamless integration with existing clinical environments. For medical image analysis, their products integrate with Picture Archiving and Communication Systems (PACS) workflows. In radiation oncology, their AutoSeg system connects directly to major Treatment Planning Systems (TPS) like Eclipse, RayStation, Monaco, and Pinnacle via DICOM. Their solutions are compatible with major CT brands such as Siemens, Philips, GE, and Canon.

Products by Ever Fortune AI

1 product in the directory

EFAI ChestSuite XR Pneumothorax Assessment System
Ever Fortune AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pneumothorax Assessment System is an FDA-cleared AI-powered radiological computer-assisted triage and notification software. It uses deep learning to analyze adult PA chest X-rays for suspected pneumothorax, sending notifications to PACS/workstations to aid in worklist prioritization and clinical assessment.

What the Web Says

Ever Fortune AI appears to be a company with two distinct public presences: one as a legitimate developer of AI solutions for healthcare, and another as a highly suspicious online platform promising easy money through AI-related tasks. The healthcare AI division focuses on medical imaging analysis for conditions like brain hemorrhage, offering high sensitivity and specificity in detection. However, numerous user reviews, particularly on Reddit, strongly suggest that the online money-making platform associated with "Ever Fortune AI" is a scam, with users reporting inability to cash out earnings, misleading promises, and fraudulent charges.

Overall: Mixed

Strengths

  • High sensitivity and specificity in detecting brain hemorrhages using non-contrast CT scans.
  • Identifies five subtypes of intracranial hemorrhage (IPH, IVH, SAH, SDH, EDH).
  • Automatically calculates midline shift for rapid triage and surgical planning.
  • Provides instant SMS notifications to doctors for prioritizing critical cases.
  • Compatible with major CT brands (Siemens, Philips, GE, Canon).
  • Aids emergency clinicians and radiologists by flagging critical cases and prioritizing worklists.

Limitations

  • Numerous reports of the online platform being a scam, with users unable to withdraw earnings.
  • Users claim misleading promises about earning potential.
  • Allegations of fraudulent credit card withdrawals.
  • Website for the online platform appears to be very new, raising red flags.
  • Some features of the healthcare AI product are only available as "Research Features" or are still under review.
  • Lack of transparency regarding the connection between the legitimate healthcare AI company and the alleged scam platform.

Based on reviews from: Reddit, EverFortune.AI Website

Last updated: 2026-10-19

Videos

News, demos, and interviews about Ever Fortune AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ever Fortune AI →

View all on YouTube

Press & Coverage

Healthcare+ B2B
Ever Fortune AI Technology's AI-Powered Endotracheal Tube Depth Detection System Secures FDA Clearance
Ever Fortune AI Technology Co., Ltd. announced that its Endotracheal Tube Depth Detection System received U.S. FDA clearance for medical use, with an application also submitted to Taiwan's TFDA.
2025-02
Healthcare+ B2B
Ever Fortune. AI Obtains TFDA Approval for AI Appendicitis Detection System, Bringing Global Regulatory Clearances to 57
Ever Fortune.AI's self-developed "Ever Fortune. AI Appendicitis Detection System" received TFDA approval, following its U.S. FDA 510(k) clearance in April 2026, bringing the company's total global regulatory approvals to 57.
2026-08
Healthcare+ B2B
Ever Fortune.AI Partners with Hospitals to Build an AI-Driven Radiotherapy Platform, Targeting AI Healthcare Opportunities
Ever Fortune.AI announced a partnership with Varian, China Medical University, Kaohsiung Veterans General Hospital, and Tungs' Taichung MetroHarbor Hospital to develop an AI Adaptive Radiotherapy Platform.
2024-12
Healthcare+ B2B
Ever Fortune.AI medical software nets one more approval for the US market
Ever Fortune.AI announced that its "EFAI RT Suite CT HCAP-Segmentation System" received FDA approval. The company specializes in neurology, cardiology, and oncology, considered "blue ocean" areas for medical AI.
2025-09
BigGo Finance
Ever Fortune.AI's "Seg Pro V3" Radiotherapy Organ Auto-Contouring System Receives U.S. FDA 510(k) Clearance and PCCP Approval
Taiwan-based medical AI company Ever Fortune.AI announced that its "Seg Pro V3" radiotherapy organ auto-contouring system has received U.S. FDA 510(k) clearance.
2026-01
Healthcare+ B2B
EVER FORTUNE AI Targets ASEAN and Western Markets with AI Medical Products, Aiming for Exponential Growth in 2025
EVER FORTUNE AI aims for significant growth in 2025 by expanding into ASEAN markets (Thailand, Malaysia, Singapore) and forming strategic alliances in Europe and the United States.
2025-01
Healthcare+ B2B
Everfortune AI Expects Revenue Growth Acceleration in H2 2026, Targets Doubled Shipments for ABO Robot in 2027
Everfortune AI anticipates increased operational momentum in the second half of 2026, driven by budget allocations and commercial shipments of its ABO medical care robot.
2026-08
China Medical University Hospital
Bridging Global Medical Innovation | A Visit from Mayo Clinic's Expert
Dr. Mohamad Adnan Alkhouli from Mayo Clinic visited China Medical University Hospital and engaged with Ever Fortune.AI, showing interest in their efforts to combine AI with advanced medical treatments.
2025-05

Frequently Asked Questions

Ever Fortune AI offers a range of AI-driven diagnostic solutions across various specialties, including oncology, neurology, and cardiology. Their products include the EFAI RT Suite CT HCAP-Segmentation System for oncology, which automates the delineation of organs-at-risk on CT images for radiotherapy planning. They also provide solutions for emergency and radiology teams, such as the Brain Hemorrhage Solution for detecting intracranial hemorrhages on CT scans, and ChestSuite for identifying pneumothorax, pleural effusion, and endotracheal tube malposition on chest X-rays. Additionally, they have an AI Appendicitis Detection System for analyzing contrast-enhanced abdominal CT scans.
Ever Fortune AI prioritizes regulatory compliance, holding numerous approvals from both Taiwan's TFDA and the U.S. FDA. As of August 2026, the company has accumulated 57 global medical device approvals, including 15 U.S. FDA clearances and 24 TFDA approvals. Their products are built to international medical device regulatory standards, ensuring validated performance and seamless integration into clinical environments.
While specific pricing models are not publicly detailed, Ever Fortune AI's solutions are designed to optimize clinical workflows, improve efficiency, and enhance patient outcomes, suggesting a value-based approach. Their systems aim to reduce waiting times, prioritize high-risk cases, and standardize care, which can lead to cost savings and improved resource allocation for healthcare institutions.
Ever Fortune AI emphasizes seamless integration with existing clinical environments. For instance, their AutoSeg system connects directly with major Treatment Planning Systems (TPS) like Eclipse, RayStation, Monaco, and Pinnacle via DICOM. Their solutions are designed to be easily incorporated into current workflows without disruption, and they offer personalized demos to explore how their products fit specific departmental needs.
Yes, Ever Fortune AI actively forms strategic partnerships to advance its AI healthcare initiatives. They have partnered with Varian, China Medical University, Kaohsiung Veterans General Hospital, and Tungs' Taichung MetroHarbor Hospital to develop an AI Adaptive Radiotherapy Platform. They are also collaborating with leading medical platforms in Europe and the U.S. for broader integration and pursuing cross-licensing agreements with other AI healthcare firms.
Ever Fortune AI is the first medical AI company in Taiwan to go public, specializing in high-value areas like neurology, cardiology, and oncology. The company has demonstrated robust operational growth, with significant increases in revenue. They have secured numerous international regulatory approvals and have a growing customer base that includes over 40 medical institutions and corporations globally.
While specific details on their data privacy and security protocols are not extensively detailed in the provided information, Ever Fortune AI builds medical big data platforms and cloud biomedical platforms. The broader medical AI industry faces challenges regarding data bias, ownership, and privacy, which often hinder widespread integration. As a company with numerous FDA and TFDA approvals, it is implied that they adhere to stringent regulatory requirements that typically include data security and privacy standards.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.